Search
Now showing items 11-20 of 25
Promising novel therapeutic approaches in the management of gastrointestinal stromal tumors
(2017)
Primary and secondary resistance to currently available licensed tyrosine kinase inhibitors poses a real clinical challenge in the management of advanced gastrointestinal stromal tumors. Within the frame of early phase ...
Role of palliative chemotherapy in advanced epithelioid sarcoma
(2012)
Background: Epithelioid sarcoma is a rare soft tissue sarcoma subtype. The response of this disease to chemotherapy is not well described. The aim of this study was to investigate the response rate and progression-free ...
Chemotherapy in clear cell sarcoma
(2011)
Clear cell sarcoma is a rare translocation-related sarcoma. There have been few studies documenting the response rate and progression-free survival in clear cell sarcoma patients treated with palliative chemotherapy. The ...
Molecular subtypes and emerging therapeutic opportunities
(Future Medicine, 2011)
Advanced soft-tissue sarcoma and treatment options: Critical appraisal of trabectedin
(2016)
Soft-tissue sarcomas (STS) are a heterogeneous group of rare solid tumors of mesenchymal origin. This paper reviews the current status of systemic treatment in advanced and metastatic soft tissue sarcomas, with an emphasis ...
Molecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications
(2017)
Gastrointestinal stromal tumors (GISTs) are composed of various molecular subtypes, with differing prognostic and predictive relevance. Previously, tumors lacking mutations in the KIT and PDGFRA genes have been designated ...